Key Record Dates Identifier: NCT03255096
Brief Title: A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6

First Submitted : July 31, 2017
First Submitted that Met QC Criteria : August 16, 2017
First Posted : August 21, 2017

Last Update Submitted that Met QC Criteria : January 27, 2021
Last Update Posted : January 28, 2021